SEARCH

SEARCH BY CITATION

REFERENCES

  • 1)
    Butler , M. A. , Iwasaki , M. , Guengerich , F. P. and Kadlubar , F. F. Human cytochrome P-450PA (P-450IA2), the phenacetin O -deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N -oxidation of carcinogenic arylamines . Proc. Natl. Acad. Sci. USA , 86 , 76967700 ( 1989 ).
  • 2)
    Kamataki , T. , Maeda , K. , Yamazoe , Y. , Matsuda , N. , Ishii , K. and Kato , R. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes . Mol. Pharmacol. , 24 , 146155 ( 1983 ).
  • 3)
    Yamazoe , Y. , Kamataki , T. and Kato , R. Species difference in N-hydroxylation of a tryptophan pyrolysis product in relation to mutagenic activation . Cancer Res. , 41 , 45184522 ( 1981 ).
  • 4)
    McManus , M. E. , Burgess , W. M. , Veronese , M. E. , Huggett , A. , Quattrochi , L. C. and Tukey , R. H. Metabolism of 2-acetylaminfluorene and benzo[a]pyrene and activation of food-derived heterocyclic amine mutagens by human cytochrome P-450 . Cancer Res. , 50 , 33673376 ( 1990 ).
  • 5)
    Butler , M. A. , Lang , N. P. , Young , J. F. , Caporaso , N. E. , Vineis , P. , Hayes , R. B. , Teitel , C. H. , Massengill , J. P. , Lawsen , M. F. and Kadlubar , F. F. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites . Pharmacogenetics , 2 , 116127 ( 1992 ).
  • 6)
    Sesardic , D. , Boobis , A. R. , Edwards , R. J. and Davis , D. S. A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O -deethylation of phenacetin and is inducible by cigarette smoking . Br. J. Clin. Pharmacol. , 26 , 363372 ( 1988 ).
  • 7)
    Hammons , G. J. , Guengerich , F. P. , Weis , C. C. , Beland , F. A. and Kadlubar , F. F. Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases . Cancer Res. , 45 , 35783585 ( 1985 ).
  • 8)
    Minchin , R. F. , McManus , M. E. , Boobis , A. R. , Davies , D. S. and Thorgeirsson , S. S. Polymorphic metabolism of the carcinogen 2-acetylaminofluorene in human liver microsomes . Carcinogenesis , 6 , 17211724 ( 1985 ).
  • 9)
    Butler , M. A. , Guengrich , F. P. and Kadlubar , F. F. Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases . Cancer Res. , 49 , 2531 ( 1989 ).
  • 10)
    Nakajima , M. , Yokoi , T. , Mizutani , M. , Shin , S. , Kadlubar , F. F. and Kamataki , T. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene . Cancer Epidemiol. Biomarkers Prev. , 3 , 413421 ( 1994 ).
  • 11)
    Nakajima , M. , Yokoi , T. , Mizutani , M. , Kinoshita , M. , Funayama , M. and Kamataki , T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans . J. Biochem. , 125 , 803808 ( 1999 ).
  • 12)
    Sambrook , J. , Fritsch , E. E. and Maniatis , T. Molecular Cloning: A Laboratory Manual2nd Ed. , pp . 916919 ( 1989 ). Cold Spring Harbor Laboratory Press , New York .
  • 13)
    Quattrochi , L. C. and Tukey , R. H. The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene . Mol. Pharmacol. , 36 , 6671 ( 1989 ).
  • 14)
    Ikeya , K. , Jaiswal , A. K. , Owens , R. A. , Jones , J. E. , Nebert , D. W. and Kimura , S. Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression . Mol. Endocrinol. , 3 , 13991408 ( 1989 ).
  • 15)
    Sesardic , D. , Pasanen , M. , Pelkonen , O. and Boobis , A. R. Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues . Carcinogenesis , 11 , 11831188 ( 1990 ).
  • 16)
    Schweikl , H. , Taylor , J. A. , Kitareewan , T. S. , Linko , P. , Nagorney , D. and Goldstein , J. A. Expression of CYP1A1 and CYP1A2 genes in human liver . Pharmacogenetics , 3 , 239249 ( 1993 ).
  • 17)
    Kalow , W. and Tang , B. K. Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking . Clin. Pharmacol. Ther. , 49 , 4448 ( 1991 ).
  • 18)
    Sachse , C. , Brockmöller , J. , Bauer , S. and Roots , I. Functional significance of a C[RIGHTWARDS ARROW]A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine . Br. J. Clin. Pharmacol. , 47 , 445449 ( 1999 ).